Navigation Links
Folic Acid Supplements Don't Affect Cancer Risk, Review Finds
Date:1/25/2013

FRIDAY, Jan. 25 (HealthDay News) -- Folic acid supplements do not affect people's risk for cancer, according to a large new review.

Short-term use of these supplements is unlikely to increase or decrease overall cancer risk and has little effect on the likelihood of developing specific cancers, such as colon, prostate, lung and breast cancers, U.K. researchers found.

The research was published online Jan. 24 in The Lancet.

"The study provides reassurance about the safety of folic acid intake, either from supplements or through fortification, when taken for up to five years," study author Robert Clarke, from the University of Oxford, said in a journal news release.

"The nationwide fortification of foods involves much lower doses of folic acid than studied in these trials, which is reassuring not only for the U.S.A., who have been enriching flour with folic acid to prevent neural tube birth defects [such as spina bifida] since 1998, but also for over 50 other countries where fortification is mandatory [such as] Australia, South Africa, Chile, Argentina and Brazil," Clarke said.

The researchers analyzed all large randomized trials of folic acid supplements with or without other B vitamins up to the end of 2010. Their analysis involved roughly 50,000 people.

Those who took folic acid every day for up to five years were not significantly more likely to develop cancer than other people who took placebo pills, the study revealed. The investigators found that 7.7 percent of those who took folic acid developed cancer, while 7.3 percent in the placebo group were also diagnosed.

Even those who took the highest average daily intake of folic acid did not increase their risk for cancer, the researchers noted. Nor did they find evidence that taking folic acid for longer periods of time increased the risk for cancer.

"Both the hopes for rapid cancer prevention and the fears about rapidly increased cancer risk from folic acid supplementation were not confirmed by this meta-analysis," Clarke said. "It remains to be seen whether any beneficial or harmful effects on cancer incidence will eventually emerge with even longer treatment or follow-up."

In an accompanying commentary, Cornelia Ulrich, director of the National Center for Tumor Diseases and German Cancer Research Center, and Joshua Miller, from Rutgers University, said it's important to note that folate may protect against the development of cancer, but also cause existing cancer cells to grow.

This is particularly important, they added, because 1 percent to 4 percent of Americans exceed the tolerable daily limit for total folic acid intake (1 milligram per day) by consuming both fortified foods and supplements.

More information

The U.S. National Library of Medicine has more about folic acid.

-- Mary Elizabeth Dallas

SOURCE: The Lancet, news release, Jan. 24, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Regal Supplements Unveils New Marquee Mobility Joint Supplement
2. Blue Sky Systems, LLC Promotes Health through Supplements via Website and Blog
3. Diabetes Support Supplements, a Product from ProactiveLife Celebrates First Year Launch
4. Fish Oil Supplements Wont Prevent Irregular Heart Beat: Study
5. Everyday Vitamin Solidifies Position in Men’s and Women’s Everyday Health with Nature's Way Alive!® Whole Food Energizer Suite of Supplements
6. Viosan Health Offers New Promotion on Omega-3 Fish Oil Pill Supplements
7. Gastric Bypass Supplements Redesigns Their Leading Website
8. Pure Cocoa Powder, the Key Ingredient in Dark Chocolate and Found in Diabetes Support Supplements has been Clinically Proven to Reduce Cardiovascular Risk
9. Despite FDA Warning, Sports Supplements Still Available Online: Study
10. Supplements of Red Wine Antioxidant Dont Help Obese Men
11. Fish, But Not Fish Oil Supplements, May Shield Against Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Folic Acid Supplements Don't Affect Cancer Risk, Review Finds
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... 2017 , ... The Honey Pot Company is thrilled to ... to ignite conversation via social media and word-of-mouth regarding vaginal health, human rights ... “Humans with Vaginas” month, releasing a video celebrating the power of strong voices ...
(Date:9/20/2017)... ... 2017 , ... Medicare doesn’t have the authority to negotiate ... their prescription drugs, according to a new comparison of drug plans by ... there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare policy ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “The Trials I ... and tribulations as he emotionally pens his aspirations and goals to better one’s life ... published author, Jimmy Green, while searching in all the wrong places, found a love ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. That’s ... and rolled up their sleeves to help with relief efforts. The team picked up ... of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms have ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a leader ... will host an educational session focused on the role ... (CLABSI) prevention at the 2017 Annual Scientific Meeting of ... take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s Prevantics® ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
(Date:9/1/2017)... -- Bayer will present the latest research from across its growing ... 2017 Congress, September 8-12 in Madrid, Spain ... data on Bayer,s marketed portfolio and late-stage compounds as well ... "We value the opportunity to meet ... ESMO," said Carsten Brunn , Head of Pharmaceuticals, Americas ...
Breaking Medicine Technology: